Guggenheim Capital, LLC Managers »

Immunovant shares owned by Guggenheim Capital, LLC Managers

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Guggenheim Capital, LLC Managers from 13F filings

Historical chart of Guggenheim Capital, LLC Managers investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Guggenheim Capital, LLC Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Guggenheim Capital, LLC Managers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 28k 42.13

More positions owned by Guggenheim Capital, LLC Managers

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cisco Systems (CSCO)
Qualcomm (QCOM)
Alphabet Cap Stk Cl C (GOOG)
Costco Wholesale Corporation (COST)
Pepsi (PEP)
Adobe Systems Incorporated (ADBE)

View all positions for Guggenheim Capital, LLC Managers

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant